skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Update on the use of Trandolapril in the management of cardiovascular disorders

Review

(2549) Views  (551) Full article downloads

Authors: Ariel Diaz, Anique Ducharme

Published Date October 2008 Volume 2008:4(6) Pages 1147 - 1158
DOI: http://dx.doi.org/10.2147/VHRM.S3467

Ariel Diaz1, Anique Ducharme2

1University of Montreal, Trois-Rivieres; 2Department of Medicine, Montreal Heart Institute Research Center, Montreal, Quebec, Canada

Abstract: Trandolapril is a well known angiotensin converting enzyme (ACE) inhibitor with many cardiovascular (CV) indications. The objectives of this article are to review the pharmacokinetics and pharmacodynamics properties of trandolapril and to focus on its clinical relevance in cardiovascular medicine. Various populations have been studied in large clinical trials including patients with congestive heart failure (CHF) after an acute myocardial infarction (AMI), diabetics, patients with hypertension (HTN), stable coronary artery disease (CAD) and prevention of proteinuria. Long-term treatment with trandolapril in patients with reduced left ventricular function soon after AMI significantly reduced the risk of overall mortality, mortality from CV causes, sudden death, and the development of severe CHF. Treatment with trandolapril after AMI complicated by left ventricular dysfunction appears to be of considerable importance in patients with diabetes mellitus by saving lives and substantially reducing the risk of progression to severe CHF as well. Moreover, trandolapril reduces progression to proteinuria in high-risk patients. Some of the advantages of trandolapril over other ACE inhibitors are the wide spectrum of patient populations studied, the well established dosage and its proven trough-to-peak effect ratios permitting a safe once-a-day administration.

Keywords: trandolapril, angiotensin converting enzyme inhibitors, hypertension cardiovascular diseases, diabetic nephropathy








Readers of this article also read:

Managing hypertension in diabetic patients – focus on trandolapril/verapamil combination
Risk stratification for arrhythmic death in an emergency department cohort: a new method of nonlinear PD2i analysis of the ECG
Hyperoxia reduces costs of digestion in snakes: potential bioenergetic consequences of the paleoatmosphere
Ethical issues in kidney transplantation – reflections from Nigeria
Are adrenaline autoinjectors fit for purpose? A pilot study of the mechanical and injection performance characteristics of a cartridge- versus a syringe-based autoinjector
Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography
Urologist-operated ultrasound and its use in urological outpatient clinics
Corrigendum: Softec HD hydrophilic acrylic intraocular lens: biocompatibility and precision
Erratum
A case of recurrent bloody tears
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University